Meneceur S, Linge A, Meinhardt M, Hering S, Löck S, Bütof R, Krex D, Schackert G, Temme A, Baumann M, Krause M, von Neubeck C.
Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma.
Cancers (Basel). 2020;12(4):871.

Suckert T, Müller J, Beyreuther E, Azadegan B, Brüggemann A, Bütof R, Dietrich A, Gotz M, Haase R, Schürer M, Tillner F, von Neubeck C, Krause M, Lühr A.
High-precision image-guided proton irradiation of mouse brain sub-volumes.
Radiother Oncol. 2020;146:205-212.

Krause M, Alsner J, Linge A, Bütof R, Löck S, Bristow R.
Specific requirements for translation of biological research into clinical radiation oncology.
Mol Oncol. 2020;14(7):1569-1576.

Dutz A, Agolli L, Bütof R, Valentini C, Baumann M, Lühr A, Löck S, Krause M.
Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.
Radiother Oncol. 2020;143:108-116.

Zschaeck S, Li Y, Bütof R, Lili C, Hua W, Troost ECG, Beck M, Amthauer H, Kaul D, Kotzerke J, Baur ADJ, Ghadjar P, Baumann M, Krause M, Hofheinz F.
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer.
Int J Cancer. 2020;147(5):1427-1436.

Bütof R, Löck S, Soliman M, Haase R, Perrin R, Richter C, Appold S, Krause M, Baumann M.
Dose-volume predictors of early esophageal toxicity in non-small cell lung cancer patients treated with accelerated-hyperfractionated radiotherapy.
Radiother Oncol. 2020;143:44-50.


Meneceur S, Löck S, Gudziol V, Hering S, Bütof R, Rehm M, Baumann M, Krause M, von Neubeck C.
Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
Radiother Oncol. 2019;137:24-31.

Aktar R, Dietrich A, Tillner F, Kotb S, Löck S, Willers H, Baumann M, Krause M, Bütof R.
Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios.
Br J Radiol. 2019;92(1095):20180539.


Vehlow, A., Klapproth, E., Storch, K., Dickreuter, E., Seifert, M., Dietrich, A., Bütof, R., Temme, A., Cordes, N. (2016). β1 integrin and JNK dependence of glioblastoma stem-like cell radiochemoresistance and invasion. Oncotarget 2017 Jul25; 8(30): 49224-49237.

Zschaeck, S., Hofheinz, F., Zöphel, K., Bütof, R., Jentsch, C., Schmollack, J., Löck, S., Kotzerke, J., Barreton, G., Weitz, J., Baumann, M., Krause, M. (2017). PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial. Eur J Nucl Med Mol Imaging 2017 doi: 10.1007/s00259-017-3742-0. [Epub ahead of print]


Hofheinz, F., Bütof, R., Apostolova, I., Zöphel, K., Steffen, I.G., Amthauer, H., Kotzerke, J., Baumann, M., van den Hoff, J. (2015). An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI Res. 2016 Dec;6(1):19.

Tillner, F., Thute, P., Löck, S., Dietrich, A., Fursov, A., Haase, R., Lukas, M., Rimarzig, B., Sobiella, M., Krause, M., Baumann, M., Bütof, R. and Enghardt, W. (2015). Precise image-guided irradiation of small animals: a flexible non-profit platform. Phys Med Biol. 2016 Apr 21;61(8):3084-108.

Zschaeck, S., Simon, M., Löck, S., Troost, EG., Stützer, K., Wohlfahrt, P., Appold, S., Makocki, S., Bütof, R., Richter, C., Baumann, M., Krause, M. (2016). PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial. Trials 2016 Nov15,
17 (1):543.


Bütof R, Krause M (2015) Tumorvolumenbestimmung ‒ Anforderungen der Strahlentherapie an die moderne radiologische Bildgebung. Der Onkologe 21: 382–387

Bütof, R., Hofheinz, F., Zöphel, K., Stadelmann, T., Schmollack, J., Jentsch, C., Löck, S., Kotzerke, J., Baumann, M., van den Hoff, J. (2015). Prognostic value of pretherapeutic tumor-to-blood standard uptake ratio (SUR) in patients with esophageal carcinoma. J Nucl Med. 2015 Aug;56(8):1150-6.


Tillner F, Thute P, Bütof R, Krause M, Rolle A Höffken G, Krause M, Enghardt W (2014) Preclinical research in small animals using radiotherapy technology - a bidirectional translational approach. Z Med Phys 24: 335–351

Bütof R, Kirchner K, Appold S, Löck S, Rolle A, Höffken G, Krause M, Baumann M (2014) Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol 190: 263–269


Bütof R, Dubrovska A, Baumann M (2013) Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol 108: 388–396

Bütof R, Baumann M (2013) Time in radiation oncology – Keep it short! Radiother Oncol 106: 271–275


Gurtner K, Deuse Y, Bütof R, Schaal K, Eicheler W, Oertel R, Grenman R, Thames H, Yaromina A, Baumann M, Krause M (2011) Diverse effects of combined radio-therapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression. Radiother Oncol 99: 323–330